News | Medilink

Featured

Medilink North of England – message to our members

We are all facing unprecedented challenges with the Covid-19 crisis. Our UK Lifescience industry has always been on the front line when it comes to responding to the changing needs of healthcare delivery but never before has this been more visible than in the current Covid-19 crisis. We have member companies working around the clock,…

European Commission delays MDR to 2021 – ACT NOW!

In light of the disruption caused by the COVID19 pandemic in Europe, The European Commission has adopted a proposal to postpone the application date of the Medical Device Regulation MDR for one year. This proposal is now expected to pass quickly through the European Parliament and Council, becoming law by the end of May 2020.…

Medilink Covid 19 pandemic update

In light of current UK Government guidance, Medilink has introduced remote working, to ensure the health and wellbeing of not just our staff, but of our members, clients and the wider sector. This includes guidance on non-critical travel and systems to allow remote meetings to take place (both internally and externally) until further notice. Medilink has…

Important announcement: UK pavilions commitment to Medica 2020

With the unprecedented circumstances caused by COVID-19, there have been a number of questions whether Medica, the largest medical technology exhibition in the world, will go ahead this year. Messe Düsseldorf, the organisers of Medica, are still planning for the show to take place from 16th to 19th November, with Medilink UK and Gambica being…

Running a business in light of the pandemic – an insight from Medilink member, Micramed

The outbreak of the COVID-19 pandemic has caused uncertainty for life sciences and healthcare businesses, which had to amend their working practices due to the introduction of safety measurements, including social distancing. How are they coping with this extraordinary situation? Rachael Benson, Director at Micramed, which is a Medilink member providing microbiology consultancy and training…

QuantumMdx launches rapid, sensitive SARS-CoV-2 test

QuantuMdx, a UK-based developer of transformational diagnostic technologies and Medilink member, has launched a SARS-CoV-2 assay which delivers results in approximately 70 minutes. Working with a British manufacturing partner, Biofortuna Limited, the company has increased the production capability up to 2 million tests a week with the potential to scale up to 3 million tests…

HGF, intellectual property specialists and Medilink partner, have shared a special COVID-19 resource library with important information and updates regarding intellectual property issues during the crisis. The resource centres includes contractual and legal considerations, information on working practices of HGF, deadlines and docketing, available funding to accelerate innovation during the crisis, a support package for…